title: Vancomycin-resistant Enterococcus faecium osteoarthritis following Staphylococcus aureus hip infection.
authors.affiliation: Dept of Experimental Medicine and Biochemistry, Clinic of Infectious Diseases, Policlinico Monteluce, 06126 Perugia, Italy.
authors.forename: Maria Bruna
authors.initials: MB
authors.lastname: Pasticci
authors.forename: Franco
authors.initials: F
authors.lastname: Baldelli
authors.forename: Lisa
authors.initials: L
authors.lastname: Malincarne
authors.forename: Giovanni Battista
authors.initials: GB
authors.lastname: Mancini
authors.forename: Massimo
authors.initials: M
authors.lastname: Marroni
authors.forename: Sabrina
authors.initials: S
authors.lastname: Morosi
authors.forename: Giuliano
authors.initials: G
authors.lastname: Stagni
mesh_terms: D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004338:Drug Combinations; D024881:Drug Resistance, Bacterial; D016984:Enterococcus faecium / Q000302:isolation & purification*; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy* / Q000209:etiology; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D015207:Osteoarthritis, Hip / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D011475:Prosthesis Failure; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome; D014640:Vancomycin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014640:Vancomycin